Skip to main navigation Skip to search Skip to main content

Killing two birds with one RKIP

  • Reema Goel
  • , Joseph J. Baldassare

Research output: Contribution to journalShort surveypeer-review

Abstract

Analysis of metastatic prostate cancers has identified the Raf kinase inhibitory protein (RKIP) as a suppressor of metastases. Previous studies demonstrated that RKIP binds to Raf-1 and prevents the activation of the extracellular regulated kinase (ERK) cascade. New work shows that phosphorylation of RKIP by protein kinase C disassociates RKIP from Raf-1 and stimulates its binding to, and inhibition of G-protein-coupled receptor kinase 2 (GRK2). This switching enhances signaling by activation of the ERK pathway and by decreased receptor desensitization.

Original languageEnglish (US)
Pages (from-to)91-92
Number of pages2
JournalTrends in Endocrinology and Metabolism
Volume15
Issue number3
DOIs
StatePublished - Apr 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint

Dive into the research topics of 'Killing two birds with one RKIP'. Together they form a unique fingerprint.

Cite this